FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    deux Is a General adjectival modifier false Inferred relationship Some
    deux Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely diphenhydramine 25 milligram and ibuprofen 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Drospirenone 2 mg and estradiol 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Glipizide 5 mg and metformin hydrochloride 500 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Ibuprofen 400 mg and oxycodone 5 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Drospirenone 500 microgram and estradiol 1 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Furosemide 20 mg and spironolactone 50 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Aztreonam 2 g powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Deferoxamine mesilate 2 g powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    ceftazidime 2 g, pour injection (poudre pour reconstitution) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False deux Inferred relationship Some 1
    Ifosfamide 2 g powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet Count of base of active ingredient False deux Inferred relationship Some
    Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet Count of base of active ingredient False deux Inferred relationship Some
    Raltitrexed 2 mg powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely somatropin(rbe) 2 milligram/1 syringe powder for conventional release solution for injection Has presentation strength numerator value False deux Inferred relationship Some 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet Count of base of active ingredient False deux Inferred relationship Some
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Mitomycin 2 mg powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 1
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength numerator value False deux Inferred relationship Some 2
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Dihydrocodeine tartrate 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Orciprenaline sulfate 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Diazepam 2 mg/mL oral suspension Has concentration strength numerator value False deux Inferred relationship Some 1
    Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Diphenhydramine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely ampicillin (as ampicillin trihydrate) 25 milligram/1 milliliter and flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Pholcodine 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False deux Inferred relationship Some
    Dicycloverine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False deux Inferred relationship Some
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1
    Midazolam (as midazolam hydrochloride) 2 mg/mL oral solution Has concentration strength numerator value False deux Inferred relationship Some 1
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream Count of base of active ingredient False deux Inferred relationship Some
    Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution (clinical drug) Has concentration strength numerator value False deux Inferred relationship Some 1

    Start Previous Page 6 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start